A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients
2020
Blood Advances
Key Points Patients with acute leukemia present with a prolonged and severe course of COVID-19, which is paralleled by high rates of viremia. Low-intensive chemotherapy seems to be more feasible in patients with acute myeloid leukemia and concomitant SARS-CoV-2 infection.
doi:10.1182/bloodadvances.2020002543
pmid:33275765
fatcat:d2hyi5jkgzdmjgexkthwtufssu